+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Dermatologicals in South Africa

  • PDF Icon

    Report

  • 24 Pages
  • October 2024
  • Region: South Africa
  • Euromonitor International
  • ID: 2640786
Value sales of dermatologicals in South Africa continue to rise in 2024, with demand increasing across the category. Strong contributors to value sales include topical germicidals/antiseptics (Zam-Buk, Dettol), topical allergy remedies/antihistamines (Phenergan), topical antifungals (Lamisil), and antiparasitics/lice (head and body) treatments (Para, Controlice).

The Dermatologicals in South Africa report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

  • Get a detailed picture of the Dermatologicals market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.

Table of Contents

KEY DATA FINDINGS
2024 DEVELOPMENTS
  • Nappy (diaper) rash treatments remains essential product for local parents
  • Price-sensitive consumers seek alternative solutions
  • Consumers rely on pharmacists when seeking dermatologicals
PROSPECTS AND OPPORTUNITIES
  • Lines between dermatologicals and dermocosmetics are blurring
  • Vaginal antifungals remain taboo to purchase in South Africa
  • Visits to a dermatologist unaffordable for many consumers
CATEGORY DATA
  • Table 1 Sales of Dermatologicals by Category: Value 2019-2024
  • Table 2 Sales of Dermatologicals by Category: % Value Growth 2019-2024
  • Table 3 NBO Company Shares of Dermatologicals: % Value 2020-2024
  • Table 4 LBN Brand Shares of Dermatologicals: % Value 2021-2024
  • Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2021-2024
  • Table 6 Forecast Sales of Dermatologicals by Category: Value 2024-2029
  • Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2024-2029
CONSUMER HEALTH IN SOUTH AFRICA
EXECUTIVE SUMMARY
  • Consumer health in 2024: The big picture
  • 2024 key trends
  • Competitive landscape
  • Retailing developments
  • What next for consumer health?
MARKET INDICATORS
  • Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
  • Table 9 Life Expectancy at Birth 2019-2024
MARKET DATA
  • Table 10 Sales of Consumer Health by Category: Value 2019-2024
  • Table 11 Sales of Consumer Health by Category: % Value Growth 2019-2024
  • Table 12 NBO Company Shares of Consumer Health: % Value 2020-2024
  • Table 13 LBN Brand Shares of Consumer Health: % Value 2021-2024
  • Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2019-2024
  • Table 15 Distribution of Consumer Health by Format: % Value 2019-2024
  • Table 16 Distribution of Consumer Health by Format and Category: % Value 2024
  • Table 17 Forecast Sales of Consumer Health by Category: Value 2024-2029
  • Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029
APPENDIX
  • OTC registration and classification
  • Vitamins and dietary supplements registration and classification
  • Self-medication/self-care and preventive medicine
  • Switches
DISCLAIMERDEFINITIONS
SOURCES
  • Summary 1 Research Sources